Skip to main navigation Skip to search Skip to main content

Phase 11 Open Label Study of CT-2106 as a Single Agent in Patients with Advanced Metastatic Ovarian Cancer Who Have Failed One Prior Platinum and Taxane Based Regimen...

  • Poole, Christopher (Principal Investigator)

Project Details

Short titlePhase 11 Open Label Study of CT-2106 as a Single Agent in Patients with Advanced Metastatic Ovarian Cancer Who Have Failed One Prior Platinum and Taxane Based Regimen...
StatusFinished
Effective start/end date1/09/04 → 31/08/06

Funding

  • CELL THERAPUTIC INC